îæ€çŽ¢
îæ€çŽ¢
î
Unicycive Therapeutics Inc
UNCYîãŠã©ãããªã¹ãã«è¿œå
4.825USD
+0.015+0.31%
ååŒæé 09/24, 14:35ïŒETïŒ
128.83Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
TradingKeyãã£ãŒã
Intraday
1m
30m
1h
D
W
M
D
æ¬æ¥
+0.31%
5æ¥é
+0.94%
1ã¶æ
-14.30%
6ã¶æ
-28.73%
幎åæ¥
-16.38%
1幎é
+21.23%
äž»èŠããŒã¿
4.828å§å€
4.960é«å€
57.07Kåºæ¥é«
æ倱é¡çŽè¿12ã¶æPER
2.65äºæ³PER
--çŽè¿12ã¶æé
åœ
0.21%売買å転ç
4.810åæ¥çµå€
4.630å®å€
269.83K売買代é
æ倱é¡æ ªäŸ¡åçç
2.42PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
-86.51%ç·è³ç£å©çç
8.74052é±é«å€
0.10åºæ¥é«æ¯ç%
-37.82MçŽå©ç
26.70Mæ ªåŒæ°
-2.25151æ ªåœããå©çïŒEPSïŒ
1.73ããŒã¿å€
-162.89%èªå·±è³æ¬å©çç
3.71052é±å®å€
6.86%æ¯ãå¹
100.00%ç²å©çç
128.83Mæ䟡ç·é¡
0.24ãªã¹ã¯ãªã¿ãŒã³
4.96%ãªã¹ã¯ç
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
Unicycive Therapeutics Incã®ã¹ã³ã¢î°î°
-0.04ååå€ã«å¯Ÿããæ¯ç
äºæž¬å€8.22
財åå¥å
šæ§3.94
ãã¯ãã«ã«3.67
ããªã¥ãšãŒã·ã§ã³6.14
æ©é¢æè³å®¶ã®ä¿¡é Œæ3.00
ãªã¹ã¯è©äŸ¡3.04
ã¡ãã£ã¢å ±é
å ±éã¬ãã«
éåžžã«äœã
éåžžã«é«ã
ãã¬ãã£ã-
ã¢ããªã¹ãè©äŸ¡î
Unicycive Therapeutics Inc ãã¯ãã«ã«åæ
îãã¯ãã«ã«ææš
売ã
èŠçŽ
売ã
移åå¹³å
匷å売ãæšå¥š
財åææšî
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åè«žè¡šî
次åå ±åæ¥
--
å ±åæé
2026Q2
財åè«žè¡š / äºæž¬
-0.06/-0.34
åç / äºæž¬
--/0.00
Unicycive Therapeutics Inc ãããã£ãŒã«î
ã»ã¯ã¿ãŒãã€ãªãã¯ãããžãŒ & å»çç 究
äŒæ¥ã³ãŒãUNCY
åŸæ¥å¡æ°22
åœUnited States of America
ä¿æç¶æ³î
| æ ªäž»çµ±èš | æ¯ç |
|---|---|
| Vivo Capital, LLC | 6.70% |
| Millennium Management LLC | 4.39% |
| Octagon Capital Advisors LP | 3.75% |
| Nantahala Capital Management, LLC | 3.52% |
| çš®é¡ | æ¯ç |
|---|---|
| Hedge Fund | 16.98% |
| Venture Capital | 8.61% |
| Investment Advisor | 4.70% |
| Individual Investor | 2.36% |
é¢é£éèåå
+3.28%
+0.87%
+0.00%
+0.56%
+0.49%
+1.33%
+0.37%
-0.33%
+0.41%
+0.92%
+1.20%
-0.67%
-0.40%
+0.04%
-1.62%
-0.53%
+3.91%
+1.39%
-1.09%
+1.53%人æ°éæ
î
51337.900
-152.100Â (-0.29%)
30414.300
-63.600Â (-0.21%)
7698.700
-8.300Â (-0.11%)
14260.000
-162.000Â (-1.12%)
65753.000
-376.000Â (-0.57%)
6304.200
+14.200Â (+0.23%)
94.433
+1.943Â (+2.10%)
337.510
+0.490Â (+0.14%)
223.860
-1.650Â (-0.73%)
4268.220
-18.020Â (-0.42%)
ãããã質å
Unicycive Therapeutics IncïŒUNCYïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îUnicycive Therapeutics IncïŒUNCYïŒã®çŸåšã®æ ªäŸ¡ã¯4.81ã§ãã
Unicycive Therapeutics Incã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îUnicycive Therapeutics Incã®ãã£ãã«ãŒã·ã³ãã«ã¯UNCYã§ãã
Unicycive Therapeutics Incã®52é±é«å€ã¯ãããã§ããïŒ
îUnicycive Therapeutics Incã®52é±é«å€ã¯8.74ã§ãã
Unicycive Therapeutics Incã®52é±å®å€ã¯ãããã§ããïŒ
îUnicycive Therapeutics Incã®52é±å®å€ã¯3.71ã§ãã
Unicycive Therapeutics Incã®æ䟡ç·é¡ã¯ãããã§ããïŒ
îUnicycive Therapeutics Incã®æ䟡ç·é¡ã¯128.43Mã§ãã
Unicycive Therapeutics Inc (UNCY) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãUnicycive Therapeutics IncïŒUNCYïŒã®ç·åè©äŸ¡ã¯è²·ãã§ãç®æšæ ªäŸ¡ã¯28.22ã§ãã
Unicycive Therapeutics Inc (UNCY) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îUnicycive Therapeutics IncïŒUNCYïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯-2.25ã§ãã